Story thread · 2 reports / 2 sources
Sarepta to pay Regenxbio $39M to settle gene therapy claims; Vida eyes 4th fund
endpts.com · 7h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
Plus news about Frazier Life Sciences, BigHat Biosciences, Kasvu Therapeutics, Arcturus Therapeutics, Oruka Therapeutics and Viking Therapeutics. Sarepta Therapeutics settles gene therapy suit: Sarepta has agreed to pay Regenxbio $39 million to
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.